M 17055

Known as: M-17055, M17055 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1992-2006
012319922006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
M17055 is under development as a novel loop diuretic for oral administration. To investigate the molecular mechanism of its… (More)
  • figure 1
  • figure 2
  • table I
  • figure 3
  • figure 4
Is this relevant?
2004
2004
M17055 was developed as a novel diuretic that inhibits both Na(+), K(+), and 2Cl(-) cotransport at the thick ascending Henle's… (More)
Is this relevant?
2002
2002
The metabolic profile of M17055, a novel diuretic, after administration to experimental animals and after incubation with human… (More)
Is this relevant?
2002
2002
1. The potential of M17055, a novel diuretic candidate, to affect the activities of human CYP enzymes, alter the plasma unbound… (More)
Is this relevant?
1996
1996
Although diuretics have been clinically shown to reduce cardiovascular morbidity and mortality, the effects of diuretics on… (More)
  • figure I
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1993
1993
We investigated the mechanism of action of a novel 'high ceiling' diuretic, M17055, in in vivo clearance studies with… (More)
Is this relevant?
1993
1993
We investigated the effects of a novel diuretic, M17055, on blood pressure and cardiovascular hypertrophy in spontaneously… (More)
Is this relevant?
1993
1993
To elucidate the mechanisms of relative anticalciuric effect of a diuretic, 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H… (More)
Is this relevant?
1993
1993
By using an in vitro microperfusion technique, we examined whether a novel loop diuretic, 7-Chloro-2,3-dihydro-1-(2-methylbenzoyl… (More)
Is this relevant?
1992
1992
7-Chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt (M17055, CAS 114417-20-8… (More)
Is this relevant?